文献速递消化内镜消化道肿瘤与早癌

实时计算机辅助检测成本效益关键因素的评估:基于微观模拟模型的敏感性与阈值分析

An Evaluation of Critical Factors for the Cost-Effectiveness of Real-Time Computer-Aided Detection: Sensitivity and Threshold Analyses Using a Microsimulation Model.
PubMed 文献 · Gastroenterology · 2023-02-02

本研究建立半马尔可夫微观模拟模型,比较传统结肠镜(平均腺瘤检出率26%)与计算机辅助检测(CAD)结肠镜(平均腺瘤检出率37%,每次操作成本75美元)的成本效益。CAD使所有内镜医师腺瘤检出率提升时,每万人减少79例结直肠癌和34例死亡,且节省成本143美元、增量效果0.01质量调整生命年。阈值分析显示CAD每次结肠镜额外成本不超过579美元或腺瘤检出率从26%提升至至少30%时具成本效益。

要点

  • CAD使所有内镜医师腺瘤检出率提升时,每万人减少79例结直肠癌和34例死亡。
  • CAD每次结肠镜成本不超过579美元或腺瘤检出率从26%升至至少30%时具成本效益。
  • CAD仅用于低腺瘤检出率(<25%)内镜医师时,每万人减少67例结直肠癌和28例死亡。

核心结论

  • CAD需将平均腺瘤检出率从26%提升至至少30%,或每次结肠镜成本低于579美元,才比传统结肠镜具成本效益。
  • 需进一步研究了解CAD在社区实践中的影响。

研究设计与样本

  • 研究建立半马尔可夫微观模拟模型,比较传统结肠镜(平均腺瘤检出率26%)与CAD结肠镜(平均腺瘤检出率37%)。
  • CAD建模为每次操作成本75美元,支付意愿阈值为100,000美元/质量调整生命年。

主要发现

  • CAD使所有内镜医师腺瘤检出率提升时,CAD队列每万人终生结直肠癌病例减少79例、死亡减少34例。
  • 该场景下CAD占优,节省成本143美元,增量效果为0.01质量调整生命年。
  • CAD仅用于低腺瘤检出率(<25%)内镜医师时,每万人结直肠癌病例减少67例、死亡减少28例。

关键数值与推荐

  • 阈值分析显示CAD每次结肠镜额外成本不超过579美元时具成本效益。
  • CAD使腺瘤检出率从26%提升至至少30%时具成本效益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究了解CAD在社区实践中的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The use of computer-aided detection (CAD) increases the adenoma detection rates (ADRs) during colorectal cancer (CRC) screening/surveillance. This study aimed to evaluate the requirements for CAD to be cost-effective and the impact of CAD on adenoma detection by endoscopists with different ADRs. METHODS: We developed a semi-Markov microsimulation model to compare the effectiveness of traditional colonoscopy (mean ADR, 26%) to colonoscopy with CAD (mean ADR, 37%). CAD was modeled as having a $75 per-procedure cost. Extensive 1-way sensitivity and threshold analysis were performed to vary cost and ADR of CAD. Multiple scenarios evaluated the potential effect of CAD on endoscopists' ADRs. Outcome measures were reported in incremental cost-effectiveness ratios, with a willingness-to-pay threshold of $100,000/quality-adjusted life year. RESULTS: When modeling CAD improved ADR for all endoscopists, the CAD cohort had 79 and 34 fewer lifetime CRC cases and deaths, respectively, per 10,000 persons. This scenario was dominant with a cost savings of $143 and incremental effectiveness of 0.01 quality-adjusted life years. Threshold analysis demonstrated that CAD would be cost-effective up to an additional cost of $579 per colonoscopy, or if it increases ADR from 26% to at least 30%. CAD reduced CRC incidence and mortality when limited to improving ADRs for low-ADR endoscopists (ADR <25%), with 67 fewer CRC cases and 28 CRC deaths per 10,000 persons compared with traditional colonoscopy. CONCLUSIONS: As CAD is implemented clinically, it needs to improve mean ADR from 26% to at least 30% or cost less than $579 per colonoscopy to be cost-effective when compared with traditional colonoscopy. Further studies are needed to understand the impact of CAD when used in community practice.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Thiruvengadam NR, Coté GA, Gupta S, et al. An Evaluation of Critical Factors for the Cost-Effectiveness of Real-Time Computer-Aided Detection: Sensitivity and Threshold Analyses Using a Microsimulation Model. Gastroenterology. 2023. PMID: 36736437. doi:10.1053/j.gastro.2023.01.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。